Chemed Corporation $CHE Shares Acquired by Intech Investment Management LLC

Intech Investment Management LLC lifted its position in shares of Chemed Corporation (NYSE:CHE) by 73.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,522 shares of the company’s stock after purchasing an additional 2,330 shares during the period. Intech Investment Management LLC’s holdings in Chemed were worth $2,363,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Smartleaf Asset Management LLC increased its position in shares of Chemed by 71.4% during the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after purchasing an additional 25 shares in the last quarter. BOK Financial Private Wealth Inc. acquired a new stake in shares of Chemed during the fourth quarter worth about $27,000. Global Retirement Partners LLC increased its position in shares of Chemed by 200.0% during the fourth quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock worth $37,000 after purchasing an additional 58 shares in the last quarter. Geneos Wealth Management Inc. increased its position in Chemed by 330.4% in the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after acquiring an additional 76 shares during the period. Finally, Danske Bank A S increased its position in Chemed by 250.0% in the 4th quarter. Danske Bank A S now owns 140 shares of the company’s stock valued at $60,000 after acquiring an additional 100 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Stock Performance

Shares of CHE stock opened at $427.04 on Thursday. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11. The stock’s 50-day moving average price is $406.89 and its 200 day moving average price is $424.47. Chemed Corporation has a 52-week low of $365.20 and a 52-week high of $569.98. The stock has a market capitalization of $5.67 billion, a PE ratio of 23.27, a price-to-earnings-growth ratio of 1.56 and a beta of 0.54.

Chemed (NYSE:CHE) last released its earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The company had revenue of $657.51 million for the quarter, compared to analysts’ expectations of $659.22 million. During the same quarter in the previous year, the firm posted $5.63 EPS. The firm’s quarterly revenue was up 1.6% on a year-over-year basis. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, equities research analysts forecast that Chemed Corporation will post 22.3 EPS for the current year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th will be given a dividend of $0.60 per share. The ex-dividend date is Thursday, May 28th. This represents a $2.40 annualized dividend and a yield of 0.6%. Chemed’s payout ratio is presently 13.08%.

Insider Transactions at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $421.13, for a total transaction of $842,260.00. Following the transaction, the chief executive officer owned 90,219 shares in the company, valued at approximately $37,993,927.47. The trade was a 2.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 3.33% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Royal Bank Of Canada boosted their price target on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research report on Monday, April 27th. Wall Street Zen upgraded Chemed from a “hold” rating to a “buy” rating in a research report on Sunday. Oppenheimer dropped their price target on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research report on Friday, February 27th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Finally, Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Two analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $501.50.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.